查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1728075

核酸樣品製備市場－全球產業規模、佔有率、趨勢、機會及預測，依產品、技術、治療領域、應用、最終用戶、地區及競爭細分，2020-2030 年預測

Nucleic Acid Sample Preparation Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Technology, By Therapeutic Area, By Application, By End Users, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球核酸樣品製備市場價值為 26.5 億美元，預計到 2030 年將達到 38.6 億美元，預測期內複合年成長率為 6.45%。該市場透過實現從各種生物來源中高效提取、純化和製備 DNA 和 RNA，在生命科學和診斷行業中發揮著至關重要的作用。分子診斷應用的日益增多、基因組研究的擴展以及全球向個人化醫療的轉變推動了市場的成長。隨著世界各地的實驗室對更有效率、可擴展的工作流程的需求，各公司正在投資自動化、創新和策略合作，以提供滿足臨床和研究環境需求的高通量解決方案。

市場概覽
預測期 2026-2030
2024年市場規模 26.5億美元
2030年市場規模 38.6億美元
2025-2030 年複合年成長率 6.45%
成長最快的領域 基於磁珠的技術
最大的市場 北美洲

關鍵市場促進因素

核酸檢測在傳染病管理的應用增加

主要市場挑戰

先進樣品製備技術成本高

主要市場趨勢

自動化與高通量系統的整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：核酸樣品製備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品（耗材、系統、配件和組件）
    • 依技術分類（基於旋轉柱的技術、基於磁珠的技術、其他技術）
    • 依治療領域（腫瘤學、傳染病、人類遺傳學/群體遺傳學、其他）
    • 按應用（基因體學、蛋白質體學、其他）
    • 按最終用戶（學術和研究機構、製藥和生物技術公司、臨床和診斷實驗室、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美核酸樣品製備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲核酸樣品製備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太地區核酸樣品製備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美核酸樣品製備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲核酸樣品製備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第13章：全球核酸樣品製備市場：SWOT分析

第 14 章：競爭格局

  • BGI Group
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Eppendorf SE
  • BIONEER CORPORATION
  • Endress+Hauser Group Services AG
  • Merck KGaA
  • Norgen Biotek Corp.
  • Aurora Biomed Inc.
  • Agilent Technologies, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 14942

The Global Nucleic Acid Sample Preparation Market was valued at USD 2.65 Billion in 2024 and is projected to reach USD 3.86 Billion by 2030, growing at a CAGR of 6.45% during the forecast period. This market plays a vital role in the life sciences and diagnostics industry by enabling the efficient extraction, purification, and preparation of DNA and RNA from various biological sources. Market growth is fueled by the increasing application of molecular diagnostics, the expansion of genomic research, and the global shift toward personalized medicine. As laboratories worldwide demand more efficient and scalable workflows, companies are investing in automation, innovation, and strategic collaborations to deliver high-throughput solutions that address the needs of both clinical and research environments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.65 Billion
Market Size 2030USD 3.86 Billion
CAGR 2025-20306.45%
Fastest Growing SegmentMagnetic-Bead Based Technology
Largest MarketNorth America

Key Market Drivers

Increased Use of Nucleic Acid Testing in Infectious Disease Management

The expanding use of nucleic acid-based testing for infectious disease management is a primary growth driver in the market. Nucleic acid tests (NATs), including RT-PCR, are now central to disease surveillance and diagnostics due to their sensitivity and accuracy. This shift from traditional diagnostic techniques has increased demand for reliable nucleic acid preparation products. According to data from the Institute for Health Metrics and Evaluation, 85 pathogens were responsible for 704 million disability-adjusted life years (DALYs) in 2019, highlighting the vast global disease burden and the urgent need for precise molecular diagnostics. During the COVID-19 pandemic, the importance of rapid viral RNA extraction was underscored, leading to a global uptick in demand for sample preparation kits and systems. This growing reliance on NATs in public health, hospital labs, and point-of-care settings continues to propel market demand for advanced sample prep technologies.

Key Market Challenges

High Cost of Advanced Sample Preparation Technologies

One of the core challenges in this market is the high cost associated with advanced nucleic acid preparation technologies. Automated systems, next-generation sequencing (NGS) compatible platforms, and specialized consumables can impose significant financial burdens on laboratories. These costs hinder the widespread adoption of such technologies, especially in low- and middle-income countries where healthcare budgets are limited. As a result, many laboratories may opt for manual or lower-cost alternatives, restricting the market's reach and delaying the broader implementation of molecular diagnostics and precision medicine.

Key Market Trends

Integration of Automation and High-Throughput Systems

The integration of automation and high-throughput technologies is a defining trend within the nucleic acid sample preparation market. Automated systems streamline complex workflows, increase throughput, and reduce human error, making them essential in clinical diagnostics and research applications. These platforms, often powered by robotics and AI-driven software, enable laboratories to handle larger volumes of samples efficiently. Automation also enhances reproducibility and consistency in results, which is vital for applications in genomics, infectious disease testing, and precision medicine. As the cost of automation technology becomes more accessible, its adoption is expected to rise significantly across a range of laboratory settings.

Key Market Players

  • BGI Group
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Eppendorf SE
  • BIONEER CORPORATION
  • Endress+Hauser Group Services AG
  • Merck KGaA
  • Norgen Biotek Corp.
  • Aurora Biomed Inc.
  • Agilent Technologies, Inc.

Report Scope:

In this report, the Global Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nucleic Acid Sample Preparation Market, By Product:

  • Consumables
  • Systems
  • Accessories & Components

Nucleic Acid Sample Preparation Market, By Technology:

  • Spin-Column Based Technology
  • Magnetic-Bead Based Technology
  • Others

Nucleic Acid Sample Preparation Market, By Therapeutics Area:

  • Oncology
  • Infectious Disease
  • Human Genetics/Population Genetics
  • Others

Nucleic Acid Sample Preparation Market, By Application:

  • Genomics
  • Proteomics
  • Others

Nucleic Acid Sample Preparation Market, By End User:

  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Other

Nucleic Acid Sample Preparation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Sample Preparation Market.

Available Customizations:

Global Nucleic Acid Sample Preparation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Nucleic Acid Sample Preparation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Systems, Accessories & Components)
    • 5.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others)
    • 5.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
    • 5.2.4. By Application (Genomics, Proteomics, Others)
    • 5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other)
    • 5.2.6. By Region
    • 5.2.7. By Company (2024)
  • 5.3. Market Map

6. North America Nucleic Acid Sample Preparation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Therapeutics Area
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nucleic Acid Sample Preparation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Therapeutics Area
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Nucleic Acid Sample Preparation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Therapeutics Area
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Nucleic Acid Sample Preparation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Therapeutics Area
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Nucleic Acid Sample Preparation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Therapeutics Area
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Therapeutics Area
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. United Kingdom Nucleic Acid Sample Preparation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Therapeutics Area
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Italy Nucleic Acid Sample Preparation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Therapeutics Area
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. France Nucleic Acid Sample Preparation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Therapeutics Area
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Therapeutics Area
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Nucleic Acid Sample Preparation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Therapeutics Area
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Nucleic Acid Sample Preparation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Therapeutics Area
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Nucleic Acid Sample Preparation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Therapeutics Area
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Nucleic Acid Sample Preparation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Therapeutics Area
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Nucleic Acid Sample Preparation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Therapeutics Area
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Therapeutics Area
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Nucleic Acid Sample Preparation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Therapeutics Area
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Therapeutics Area
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Nucleic Acid Sample Preparation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Therapeutics Area
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Nucleic Acid Sample Preparation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Therapeutics Area
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Nucleic Acid Sample Preparation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By Therapeutics Area
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Nucleic Acid Sample Preparation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Therapeutics Area
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Therapeutics Area
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Nucleic Acid Sample Preparation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Therapeutics Area
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Nucleic Acid Sample Preparation Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. BGI Group
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. F. Hoffmann-La Roche Ltd
  • 14.3. Danaher Corporation
  • 14.4. Eppendorf SE
  • 14.5. BIONEER CORPORATION
  • 14.6. Endress+Hauser Group Services AG
  • 14.7. Merck KGaA
  • 14.8. Norgen Biotek Corp.
  • 14.9. Aurora Biomed Inc.
  • 14.10.Agilent Technologies, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer